Study Details | A Phase 3 randomized controlled study of REACT in participants with Type 2 Diabetes |
Protocol Number | REGEN-016 |
Phase | III |
Therapeutic Area | Nephrology |
Subject Types | With Medical Condition |
Indication | Type 2 Diabetes |
Principal Investigator | A/Prof Jimmy Teo Boon Wee |
Investigator Product / Device | REACT |
Sponsor | ProKidney Corp |